Hoxha et al. found that THSD7A-positive patients with membranous nephropathy, whose tumor foci exhibited significantly elevated expression levels of THSD7A mRNA, showed an increased risk for cancer development [13]. This evidence concerns the gene THSD7A and membranous glomerulonephritis.